Back to results
US 12,606,571 B2Granted
Macrocyclic compounds and uses thereof
AssigneeTurning Point Therapeutics, Inc.
InventorsJingrong Jean Cui, Evan W. Rogers, Jane Ung, Jeffrey Whitten, Dayong Zhai, Wei Deng, Xin Zhang, Zhongdong Huang, Jing Liu, Han Zhang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.
Claims9
A compound having the structure:
- or a salt thereof.
A compound having the structure:
A compound having the structure:
Dependencies are inferred from the claim text.